The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Abroad (travel likely)RecruitingPHASE4
Conditions
Primary Sjögren's Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Second affiliated hospital of zhejiang university，school of medical, Hangzhou, Zhejiang, China
Study leads
Yongmei Han
Principal Investigator
Sir Run Run Shaw Hospital
Hongzhi Wang
Principal Investigator
Affiliated Hospital of Jiaxing University
Ying Guan
Principal Investigator
Zhuji People's Hospital of Zhejiang Province